Topic specific news, updated constantly
from the most reliable sources, all in one place.
Other NewsOnly
Information Pages
Information Pages
Human Genome Sciences reports net income of $5.7 million for 2009 - Washington Post
Human Genome Sciences reports net income of $5.7 million for 2009 Washington Post The firm's drug, Benlysta, and Zalbin have both passed "Phase 3" testing. Stephen Dunn, an analyst with LifeTech Capital, said the HGS drug is ... Human Genome Sciences rises after 4Q report HGSI posts 300% increase in 4Q revenue Human Genome Sciences Announces Fourth-Quarter and Full-Year 2009 Financial ... |
Participate in the LFA's Advocacy Day on Tuesday, March 16 -- from the Comfort ... - ScienceBlog.com (blog)
Participate in the LFA's Advocacy Day on Tuesday, March 16 -- from the Comfort ... ScienceBlog.com (blog) Hundreds of advocates from around the country will come together on Capitol Hill to educate Members of Congress about , and encourage them to ... |
Piper Jaffray Assumes Coverage on Human Genome Sciences (HGSI) with an ... - StreetInsider.com (subscription)
Piper Jaffray Assumes Coverage on Human Genome Sciences (HGSI) with an ... StreetInsider.com (subscription) Our revenue forecast for Benlysta is 10-15% above the Street from 2012-2015, with potential for additional upside dependent on adoption in patients ... |
Baker up for another term - Williamsport Sun-Gazette
Baker up for another term Williamsport Sun-Gazette He serves on the Firefighters & Emergency Services, Local Tax Reform, and Diabetes and caucuses as well as the Pennsylvania Rural Health Association ... Baker seeks re-election |
Celebs Tweet about news of Corey Haim's death - FOXNews (blog)
 Globe and Mail | Celebs Tweet about news of Corey Haim's death FOXNews (blog) I just saw him last week at a event!" Fellow 80's teen star Christina Applegate wrote "My thoughts go out to Corey's family and friends today. So sad. ... Alyssa Milano on Ex Corey Haim's Death: "RIP Sweet Boy" Celebrities Remember Corey Haim on Twitter Celebs tweet about Haim |
Rheumatoid arthritis treatment suspended - Pharmaceutical Technology Magazine
Rheumatoid arthritis treatment suspended Pharmaceutical Technology Magazine The decision follows a recommendation made by the independent Ocrelizumab RA & Data and Safety Monitoring Board based on studies in RA and lupus. ... |
Human Genome names David Southwell as its CFO - Reuters
Human Genome names David Southwell as its CFO Reuters Human Genome's shares have skyrocketed since last year, when it reported unexpectedly strong data from a trial of its experimental drug Benlysta. ... Human Genome Sciences Appoints David P. Southwell Executive Vice President and ... Human Genome Sciences names David Southwell CFO Human Genome Director Southwell to Be Finance Chief |
Anthem customers in Colorado face higher rates during inquiry - Denver Post
Anthem customers in Colorado face higher rates during inquiry Denver Post Laurie Brock, a 60-year-old sufferer, moved to an insurance plan with a higher deductible after Anthem Blue Cross Blue Shield hiked ... |
Psychotherapy Can Help People With Cope - BusinessWeek
Psychotherapy Can Help People With Lupus Cope BusinessWeek TUESDAY, March 9 (HealthDay News) -- Psychotherapy helps cut the incidence of psychological woes in patients with who have high levels of daily stress ... |
Investors Unfazed by Roche-Biogen Idec Testing Troubles - Seeking Alpha (blog)
 The Hindu | Investors Unfazed by Roche-Biogen Idec Testing Troubles Seeking Alpha (blog) PK) and Biogen Idec (BIIB) have suspended phase III trials of ocrelizumab in rheumatoid arthritis (RA) and was the limited impact it had on the shares ... Roche, Biogen Suffer Setback With Experimental Drug The Opportunity That Wasn't The Ticker |